Ryman Healthcare Limited (NZE:RYM)
New Zealand · Delayed Price · Currency is NZD | Market Cap | 2.29B -8.5% |
| Revenue (ttm) | 854.47M +12.6% |
| Net Income | -171.35M |
| EPS | -0.17 |
| Shares Out | 1.01B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 702 |
| Open | 2.260 |
| Previous Close | 2.260 |
| Day's Range | 2.260 - 2.260 |
| 52-Week Range | 1.990 - 3.050 |
| Beta | 0.33 |
| Analysts | Buy |
| Price Target | 3.01 (+33.19%) |
| Earnings Date | May 26, 2026 |
About Ryman Healthcare
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia. The company’s villages provide apartments and townhouses, and assisted-living in serviced apartments, and care center, which offers rest homes, hospitals, specialist dementia care, and respite care services. Ryman Healthcare Limited was founded in 1984 and is based in Christchurch, New Zealand. [Read more]
Financial Performance
In fiscal year 2026, Ryman Healthcare's revenue was 854.47 million, an increase of 12.55% compared to the previous year's 759.16 million. Losses were -171.35 million, -66.65% less than in 2025.
Financial StatementsNews
Ryman Healthcare Earnings Call Transcript: H2 2026
FY 2026 saw a doubling of operating EBITDAF, positive free cash flow, and strengthened balance sheet, driven by cost savings, improved care occupancy, and disciplined capital allocation. The outlook for FY 2027 focuses on cash flow, care earnings, and reducing vacant stock.
Ryman Healthcare Slides: H2 2026
Ryman Healthcare has posted slides in relation to its H2 2026 quarterly earnings report, which was published on May 25, 2026.
Ryman Healthcare Annual report: H2 2026
Ryman Healthcare has published its H2 2026 annual report on May 25, 2026.
Ryman Healthcare Earnings release: H2 2026
Ryman Healthcare released its H2 2026 earnings on May 25, 2026, summarizing the period's financial results.
Ryman Healthcare Transcript: Investor Day 2026
A refreshed strategy prioritizes sustainable recurring earnings, operational excellence, and disciplined capital management, targeting NZD 150 million in cash flow improvement and NZD 500 million in cash release by FY 2029. Portfolio optimization, product innovation, and a new dividend policy underpin long-term value creation.
Ryman Healthcare Slides: FY 2026
Ryman Healthcare has posted slides in relation to its FY 2026 quarterly earnings report, which was published on February 2, 2026.
Ryman Healthcare Earnings Call Transcript: H1 2026
Positive free cash flow and 13% revenue growth were achieved, with cost savings ahead of target and refinancing completed. Sales guidance was updated, margins moderated due to market conditions, and significant cash release opportunities remain in inventory and development assets.
Ryman Healthcare Quarterly report: H1 2026
Ryman Healthcare has published its H1 2026 quarterly earnings report on November 26, 2025.
Ryman Healthcare Slides: H1 2026
Ryman Healthcare has posted slides in relation to its H1 2026 quarterly earnings report, which was published on November 26, 2025.
Ryman Healthcare Earnings release: H1 2026
Ryman Healthcare released its H1 2026 earnings on November 26, 2025, summarizing the period's financial results.
Ryman Healthcare Transcript: AGM 2025
The AGM addressed significant financial losses, a major board and executive refresh, and a strategic reset focused on cash generation, cost reduction, and disciplined growth. Shareholders engaged robustly on development risks, capital management, and future dividends, with management emphasizing transparency and a path to recovery.
Ryman Healthcare Slides: FY 2025
Ryman Healthcare has posted slides in relation to its FY 2025 quarterly earnings report, which was published on July 29, 2025.